NETHERLANDS COMPOUNDING PHARMACIES MARKET ANALYSIS

Netherlands Compounding Pharmacies Market, By Product Type (Mouthwashes, Oral Medication (Capsule, Lollipops, Lozenges, Suspensions,Tablets), Suppositories Topical Medication (Cream, Gels, Lotions, Ointments)), By Application (Medication for Adults, Medication for Children, Medication for Geriatric, Medication for Veterinary), By Therapeutic Area (Hormone Replacement Therapy, Pain Management), By Facilities (Community Pharmacies, Hospitals) - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027

Published In : Dec 2019
Code : CMI3156
Pages :85
Formats :
Excel and PDF
Industry : Pharmaceutical

Market News

Netherlands Compounding Pharmacies Market: Key Developments

Key players in the market are focused on geographical expansion through M&A activities. For instance, in May 2019, Fagron entered into an agreement to acquire Central de Drogas, S.A. de C.V., a leading supplier of raw materials to compounding pharmacies and the pharmaceutical industry in Mexico.

Key players in the market are also focused on product development to expand their product portfolio. For instance, in November 2018, AMC, a hospital in Amsterdam focused on producing compounding drugs, received permission from the Dutch Health and Youth Care Inspectorate to produce an equivalent of chenodeoxycholic acid (CDCA) if the used resources meet the quality standards.